From regulatory strategy and FDA submissions to precision medicine, diagnostics, and commercialization, we help life science organizations accelerate innovation with confidence.

Regulatory strategy planning, regulatory risk analysis, de-risking strategies for drug and diagnostic development and approvals
Least burdensome approaches for adaptability and flexibility
Strategies for biomarker identification, validation, CDx testing and patient selection in clinical trials
Balancing innovation with business objectives and harmonizing innovation with strategic goals

Support in preparation of Q-subs, Breakthrough Device Designation requests, 510(k)s, PMAs, PMA supplements, De Novo submissions, PCCPs, IDEs
Mock review of FDA submissions and pressure testing ideas
Effective project management

Comprehensive support in selection of sampling approaches, preparation of analytical and clinical validation plans, study protocols and reports, data development plans
Strategic guidance and pivoting tailored approaches for analytical validation and clinical evidence generation for liquid-biopsy and tissue-biopsy based assays
Product development under design control utilizing a phase-gated approach, with defined milestones

Specialized in IVDs/LDTs across various disease areas including oncology, neurology, infectious diseases, rare diseases, toxicology, pharmacogenomics, STI, women's health
Strong expertise in genomics, proteomics, molecular, cellular, and protein-based assays
Proficient in digital biomarkers, digital pathology, AI/ML enabled novel clinical diagnostics, and SiMD & SaMD

Market intelligence, market trend and competitive landscape analysis
Support high complexity CLIA clinical labs and IVD manufacturers for Point of Care (PoC), OTC/DTC, at-home tests and at-home sample collection kits, IVDs offered as single-site LDT tests, and distributed kit models for decentralized testing
Adapting strategies to diverse market segments and intended use settings

Strategic planning for biomarker strategy and technology assessment
Support for the integration of genomic testing approaches into the existing clinical processes and healthcare settings
Data & cloud strategies for large-scale genomic and clinical data
Due-diligence of technologies, companies, and precision medicine initiatives for market potential
Market development support for opportunities in the precision medicine space

Guidance and support to build Quality Management System (QMS) in compliance with 21 CFR 820 and ISO 13485
Conducting comprehensive gap analysis and implementing remediation strategies for clinical diagnostic laboratories transitioning from CLIA/CAP regulations to FDA regulatory compliance under FDA's new LDT rule, ensuring adherence to quality standards and requirements
Understand your science, goals, and regulatory landscape.
Build a practical strategy aligned with business and regulatory objectives.
Support submissions, implementation, commercialization, and long-term success.
Understand your science, goals, and regulatory landscape.
Build a practical strategy aligned with business and regulatory objectives.
Support submissions, implementation, commercialization, and long-term success.
Biotechnology
Diagnostics
Pharmaceutical
Medical Devices
Digital Health
Precision Medicine
Schedule a free consultation to discuss your needs and discover how we can help you thrive.

Expert Consulting from Concept to Commercialization in Precision Medicine
Regulatory Strategy Development
Regulatory Support for FDA Submissions
IVD and CDx Development Support
Diagnostic Technologies Across Disease Areas
Market Segmentation and Analysis
Integrating Precision Medicine & Genomic Testing
Quality Management System Implementation
(301) 919-8573
(301) 919-8573
Copyright 2026. Blue Tulip Solutions LLC. Privacy Policy. All rights reserved.